Year: 2019
Type: article
Institutions: Brigham and Women's Hospital, Harvard University, Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine, Vanderbilt University, Vanderbilt University Medical Center, Goethe University Frankfurt, Stanford Medicine, Stanford University, Ludwig-Maximilians-Universität München, Dana-Farber Cancer Institute
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funders: Burroughs Wellcome Fund, American Heart Association, Kavli Foundation, Amgen, Bristol-Myers Squibb, Pfizer, AstraZeneca, Novartis, Sanofi, Brigham and Women's Hospital, Celgene, Memorial Sloan-Kettering Cancer Center, Edward P. Evans Foundation, Regeneron Pharmaceuticals, Deutsches Zentrum für Herz-Kreislaufforschung, Astex Pharmaceuticals, MyoKardia, XBiotech, Deutsche Forschungsgemeinschaft, Fondation Leducq, Astellas Pharma, Esperion Therapeutics, National Institutes of Health, National Heart, Lung, and Blood Institute, National Cancer Institute
Awards: G1872264077, Novel mechanisms and predictors of VEGF receptor inhibitor-associated hypertension, G2051006376, G289723095, G3693892073, G395422926, G4040633995, G4102770861, G4805940643, G5809586005, G5909372135, G6393038893, G6516949535, Development of non-invasive diagnostic tools and therapeutic agents for superficial erosion using nanotechnology, G9000003249, Cancer Center Support Grant
OpenAlex ID: W2963903719